StonvexLoading…
StonvexCore line items from CRWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-03 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $1.39B | $4.81B | $3.51B | $2.27B | $1.10B |
Operating Income | Not available | $-293.29M | $-307.08M | $-237.63M | $-124.66M |
Net Income | Not available | $-162.50M | $-221.88M | $-187.88M | $-110.21M |
EPS (Diluted) | $1.09 | $-0.65 | $-0.89 | $-0.75 | $-0.44 |
Total Assets | Not available | $11.09B | $9.97B | $9.29B | $8.72B |
Total Liabilities | Not available | $6.61B | $5.91B | $5.49B | $5.23B |
Cash & Equivalents | Not available | $5.23B | $4.80B | $4.97B | $4.61B |
Free Cash Flow OCF − CapEx | Not available | $1.31B | $914.84M | $600.69M | $298.36M |
Shares Outstanding | Not available | 250.58M | 249.91M | 249.18M | 248.43M |